A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(7 sites)

United States

Academic Urology and Urogynecology of Arizona, Peoria, Arizona

Colorado Clinical Research, Lakewood, Colorado

Urology Associates, Littleton, Colorado

Chesapeake Urology Research Associates, Towson, Maryland

Sheldon Freedman, MD Ltd., Las Vegas, Nevada

Summit Health, Saddle Brook, New Jersey

START Carolinas, Myrtle Beach, South Carolina